Mijia Lu

7PUBLICATIONS
42CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsMolecular targetsVirologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 07, 2023
Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.

Mohamed M Shamseldin, Adam Kenney, Ashley Zani

|Aug 22, 2022
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.

Mijia Lu, Michelle Chamblee, Yuexiu Zhang

|May 19, 2022
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis.

Mostafa M Eltobgy, Ashley Zani, Adam D Kenney

|Dec 20, 2021
Viral RNA N6-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus.

Miaoge Xue, Yuexiu Zhang, Haitao Wang

|Jul 29, 2021
N6-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses.

Hideki Terajima, Mijia Lu, Linda Zhang

|Mar 10, 2021
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.

Mijia Lu, Piyush Dravid, Yuexiu Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Mahesh Kc

3 joint publications

Supranee Chaiwatpongsakorn

3 joint publications

Prosper N Boyaka

3 joint publications

Mark E Peeples